Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
OCH
170
CHF
CHF 170.00
In stock
AG-CR1-3593-C250250 µgCHF 170.00
AG-CR1-3593-M0011 mgCHF 360.00
| Product Details | |
|---|---|
| Synonyms | (2S,3S,4R)-1-O-(α-D-Galactopyranosyl)-N-tetracosanoyl-2-amino-1,3,4-nonanetriol) |
| Product Type | Chemical |
| Properties | |
| Formula |
C39H77NO9 |
| MW | 704.0 |
| CAS | 383187-82-4 |
| Purity Chemicals | ≥95% |
| Appearance | White to off-white solid. |
| Solubility | Soluble in DMSO, 100% ethanol (warm) or methanol (warm). |
| Identity | Determined by 1H-NMR. |
| InChi Key | MPKIDHIOYNMFES-CLTBVUQJSA-N |
| Smiles | CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COC1OC(CO)C(O)C(O)C1O)C(O)[C@H](O)CCCCC |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
After standard reconstitution, prepare aliquots and store at -20°C. Aliquot into glass vials. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Truncated analog of α-GalCer.
- iNKT cell glycolipid agonist.
- Immunosuppressive.
- Th2 polarizing. Stimulation of NKT with OCH results in release of primarily Th2 cytokine compared to stimulation with α-GalCer, which results in release of a mixture of Th1 and Th2 cytokines.
- Induces stronger interleukin-4 (IL-4) secretion and weaker interferon-γ (IFN-γ) secretion than α-GalCer both in vitro and in vivo.
- Inducer of interleukin-10 (IL-10) and suppressor of diabetes.
- Shown to prevent experimental autoimmune encephalomyelitis (EAE) in mice, an animal model of multiple sclerosis.
- Has beneficial effects on type I diabetes in NOD mice.
- Suppressor of collagen-induced arthritis.
- Might be useful for immunotherapy of transplant rejection.
Product References
- A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells: K. Miyamoto, et al.; Nature 413, 531 (2001)
- Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice: M. Mizuno, et al.; J. Autoimmun. 23, 293 (2004)
- The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells: S. Oki, et al.; J. Clin. Invest. 113, 1631 (2004)
- Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide: A. Chiba, et al.; Arthritis Rheum. 50, 305 (2004)
- Total synthesis of an immunosuppressive glycolipid, (2S,3S,4R)-1-O- (alpha-d-galactosyl)-2- tetracosanoylamino-1,3,4-nonanetriol: K. Murata, et al.; J. Org. Chem. 70, 2398 (2005)
- Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH: R.M. Ndonye, et al.; J. Org. Chem. 70, 10260 (2005)
- IFN-γ–mediated negative feedback regulation of NKT-cell function by CD94/NKG2: T. Ota, et al.; Blood 106, 184 (2005)
- Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides: Y. KO, et al.; PNAS 102, 3383 (2005)
- α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles: L. Van Kaer; Nat. Rev. Immunol. 5, 31 (2005)
- Glycolipids for natural killer T cells: P.B. Savage, et al.; Chem. Soc. Rev. 351, 771 (2006)
- Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH: S.M. Haeryfar, et al.; Transplantation 86, 460 (2008)
- Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells: B.A. Sullivan, et al.; J. Immunol. 184, 141 (2010)
- A molecular basis for the exquisite CD1d-restricted Antigen-specificity and functional responses of Natural Killer T cells: K.S. Wun, et al.; Immunity 34, 327 (2011)
- Structural and functional characterization of a novel non-glycosidic iNKT agonist with immunomodulatory properties: J. Kerzerho, et al.; J. Immunol. 188, 2254 (2012)
- Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide): M. Shiozaki, et al.; Carbohydr. Res. 370, 46 (2013)
- iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo: H. Bassiri, et al.; Cancer Immunol. Res. 2, 59 (2014)
- Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice: M. Hoya, et al.;Am. J. Reprod. Immunol. ahead of print (2018)
Related Products
